WO2002030506A3 - Transdermal method - Google Patents

Transdermal method Download PDF

Info

Publication number
WO2002030506A3
WO2002030506A3 PCT/IL2001/000941 IL0100941W WO0230506A3 WO 2002030506 A3 WO2002030506 A3 WO 2002030506A3 IL 0100941 W IL0100941 W IL 0100941W WO 0230506 A3 WO0230506 A3 WO 0230506A3
Authority
WO
WIPO (PCT)
Prior art keywords
transporting
skin surface
blister
keratolytic agent
ejecting
Prior art date
Application number
PCT/IL2001/000941
Other languages
French (fr)
Other versions
WO2002030506A2 (en
Inventor
Amiram Carmon
Benyamina Rosenberg-Hagen
Eliezer Rosenmann
Original Assignee
Ink Jet Tech Ltd
Amiram Carmon
Benyamina Rosenberg-Hagen
Eliezer Rosenmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL13896300A external-priority patent/IL138963A0/en
Priority claimed from IL14207601A external-priority patent/IL142076A0/en
Application filed by Ink Jet Tech Ltd, Amiram Carmon, Benyamina Rosenberg-Hagen, Eliezer Rosenmann filed Critical Ink Jet Tech Ltd
Priority to AU2002210881A priority Critical patent/AU2002210881A1/en
Publication of WO2002030506A2 publication Critical patent/WO2002030506A2/en
Publication of WO2002030506A3 publication Critical patent/WO2002030506A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for transport through a skin surface comprising (i) applying a microdosing device to the skin surface, (ii) ejecting from the device a keratolytic agent onto the skin surface thereby forming at least one blister containing interstitial fluid, and (iii) transporting an active agent into the blister, transporting interstitial fluid from the blister, or both. The keratolytic agent is not cantharidine. Also disclosed is a microdosing device comprising at least two sets of conduits, a first set capable of ejecting an keratolytic agent and a second set capable of transporting a liquid.
PCT/IL2001/000941 2000-10-12 2001-10-11 Transdermal method WO2002030506A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002210881A AU2002210881A1 (en) 2000-10-12 2001-10-11 Transdermal method

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL138963 2000-10-12
IL13896300A IL138963A0 (en) 2000-10-12 2000-10-12 Double action controlled transdermal drug delivery
IL142076 2001-03-19
IL14207601A IL142076A0 (en) 2001-03-19 2001-03-19 Means and methods for increasing permeation in transdermal drug delivery combined with drawing of biological analytes

Publications (2)

Publication Number Publication Date
WO2002030506A2 WO2002030506A2 (en) 2002-04-18
WO2002030506A3 true WO2002030506A3 (en) 2002-08-15

Family

ID=26323980

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2001/000941 WO2002030506A2 (en) 2000-10-12 2001-10-11 Transdermal method

Country Status (2)

Country Link
AU (1) AU2002210881A1 (en)
WO (1) WO2002030506A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9550053B2 (en) 2011-10-27 2017-01-24 Kimberly-Clark Worldwide, Inc. Transdermal delivery of high viscosity bioactive agents

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093818A2 (en) * 2003-04-21 2004-11-04 Stratagent Life Sciences Apparatus and methods for repetitive microjet drug delivery
CN101505818A (en) * 2006-08-21 2009-08-12 皇家飞利浦电子股份有限公司 Drug delivery device with piezoelectric actuator
US9033898B2 (en) 2010-06-23 2015-05-19 Seventh Sense Biosystems, Inc. Sampling devices and methods involving relatively little pain
US9119578B2 (en) 2011-04-29 2015-09-01 Seventh Sense Biosystems, Inc. Plasma or serum production and removal of fluids under reduced pressure
WO2010101620A2 (en) 2009-03-02 2010-09-10 Seventh Sense Biosystems, Inc. Systems and methods for creating and using suction blisters or other pooled regions of fluid within the skin
SG170622A1 (en) * 2009-10-09 2011-05-30 Nitto Denko Corp A passive drug delivery device and a method of drug delivery
WO2011094573A1 (en) 2010-01-28 2011-08-04 Seventh Sense Biosystems, Inc. Monitoring or feedback systems and methods
EP2563455A4 (en) 2010-04-28 2014-02-19 Kimberly Clark Co Method for increasing permeability of an epithelial barrier
WO2011135531A2 (en) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. MEDICAL DEVICES FOR DELIVERY OF siRNA
WO2011135530A2 (en) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. Device for delivery of rheumatoid arthritis medication
WO2011135533A2 (en) 2010-04-28 2011-11-03 Kimberly-Clark Worldwide, Inc. Nanopatterned medical device with enhanced cellular interaction
WO2012009613A1 (en) 2010-07-16 2012-01-19 Seventh Sense Biosystems, Inc. Low-pressure environment for fluid transfer devices
WO2012021801A2 (en) 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Systems and techniques for monitoring subjects
CN103370007B (en) 2010-11-09 2018-12-18 第七感生物系统有限公司 System and interface for blood sampling
KR102013466B1 (en) 2011-04-29 2019-08-22 세븐쓰 센스 바이오시스템즈, 인크. Delivering and/or receiving fluids
US20130158468A1 (en) 2011-12-19 2013-06-20 Seventh Sense Biosystems, Inc. Delivering and/or receiving material with respect to a subject surface
WO2012149155A1 (en) 2011-04-29 2012-11-01 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
US20170246439A9 (en) 2011-10-27 2017-08-31 Kimberly-Clark Worldwide, Inc. Increased Bioavailability of Transdermally Delivered Agents
EP3542851B1 (en) 2011-10-27 2021-12-15 Sorrento Therapeutics, Inc. Implantable devices for delivery of bioactive agents
US9459201B2 (en) 2014-09-29 2016-10-04 Zyomed Corp. Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279544A (en) * 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
WO1997003718A1 (en) * 1995-07-14 1997-02-06 Boehringer Ingelheim Kg Transcorneal drug-release system
WO1998000193A1 (en) * 1996-07-03 1998-01-08 Altea Technologies, Inc. Multiple mechanical microporation of skin or mucosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (en) 1972-02-14 1973-08-13 Ici Ltd DRESSINGS
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US6009345A (en) 1992-08-17 1999-12-28 Genetronics, Inc. Method and apparatus for a combination of electroporation and iontophoresis for the delivery of drugs and genes
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
ES2195151T3 (en) 1996-06-18 2003-12-01 Alza Corp IMPROVEMENT OR SAMPLING DEVICE FOR TRANSDERMAL AGENTS.
ATE221400T1 (en) 1997-12-11 2002-08-15 Alza Corp DEVICE FOR INCREASE THE TRANSDERMAL FLOW OF ACTIVE INGREDIENTS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279544A (en) * 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
WO1997003718A1 (en) * 1995-07-14 1997-02-06 Boehringer Ingelheim Kg Transcorneal drug-release system
WO1998000193A1 (en) * 1996-07-03 1998-01-08 Altea Technologies, Inc. Multiple mechanical microporation of skin or mucosa

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9550053B2 (en) 2011-10-27 2017-01-24 Kimberly-Clark Worldwide, Inc. Transdermal delivery of high viscosity bioactive agents

Also Published As

Publication number Publication date
AU2002210881A1 (en) 2002-04-22
WO2002030506A2 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
WO2002030506A3 (en) Transdermal method
CA2409942A1 (en) Surface treatment of medical device
WO1999055312A3 (en) Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
WO2000042961A3 (en) Water-flux limiting cleansing articles
WO2004045671A3 (en) Microstructure roller system
DE69514234D1 (en) SURFACE-LOCALIZED EXPRESSION OF ENZYMES IN GENERAL-CONTROLLED PRODRUG THERAPY
WO1999063946A3 (en) Improved methods and apparatus for storing chemical compounds in a portable inhaler
MXPA05006503A (en) Surface treatment of medical device.
AU9027498A (en) Application of substances on a package
EP1111442A4 (en) Treating agent for liquid crystal alignment layer and liquid crystal device using the same, and method for alignment of liquid crystal
WO2001003917A3 (en) Multilayered film containing an active substance and made of cross-linked hydrophilic polymers
WO1999037340A3 (en) Biological fluid treatment system
MY113548A (en) Process for the production of transdermal therapeutic patches (tts)
SI1051174T1 (en) Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
AU4725799A (en) Liquid transfer device, and use of the device for irrigation
WO2005035142A3 (en) Liquid product applicator
WO2002094174A3 (en) Container and method for dispensing transdermal dosage forms
WO2002098482A3 (en) System for osmotic delivery of pharmaceutically active agents
WO2003039620A3 (en) Integrated transdermal drug delivery system
EP0777265A3 (en) Method and device for dissolving surface layer of semiconductor substrate
CA2318468A1 (en) Method of forming interconnections between channels and chambers
WO2001082874A3 (en) A medicinal aerosol formulation
WO2005041883A3 (en) Reduction of unintended use of transdermal devices
GB9917416D0 (en)
SE0103276D0 (en) Device for administering ointment to a skin surface

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP